| | The case for implantable cardiac defibrillators, cardiac resynchronization therapy in older patients
| | Although implantable cardiac defibrillators reduce mortality through primary and secondary prevention of cardiac arrest, and cardiac resynchronization therapy improves exercise tolerance, quality of life, and decreases mortality and hospitalizations, both strategies are underutilized in older patients. Recommending device placement to patients requires a discussion of indication, risks, and benefits, as well as plans for deactivation in end-stage disease. | |  |
|
|
| | | The case for implantable cardiac defibrillators, cardiac resynchronization therapy in older patients
| | | Although implantable cardiac defibrillators reduce mortality through primary and secondary prevention of cardiac arrest, and cardiac resynchronization therapy improves exercise tolerance, quality of life, and decreases mortality and hospitalizations, both strategies are underutilized in older patients. Recommending device placement to patients requires a discussion of indication, risks, and benefits, as well as plans for deactivation in end-stage disease. |
| | | Elevated CRP alone doesn't justify statin treatment
| | | C-reactive protein (CRP) doesn't add predictive value to traditional cardiovascular risk factors, and there does not appear to be a causal association between CRP and coronary heart disease (CHD), according to results of two studies published in the July 1, 2009, issue of the Journal of the American Medical Association. |
|
| 
Practice Tools
